Veristat and AOBiome Therapeutics to Present at Clinical Outsourcing Group on Essential...
Southborough, MA - Oct. 7, 2025 – Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies,...
Cook MyoSite and Veristat Partner in Complex, Phase III, Adaptive Clinical Study of...
Veristat partners to achieve key enrollment milestone for study; activated 26 sites and enrolled over 100 participants
Veristat Achieves EcoVadis Committed Badge: A Milestone in Our Sustainability Journey
We're proud to announce that Veristat has received our first EcoVadis Committed Badge, marking a significant milestone in our commitment to...
Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™
Proud to Collaborate in Delivering a Groundbreaking, First-in-Class Therapy to Patients in Need
Veristat Appoints Industry Veteran Kim McLean Boericke as its Chief Operating Officer
Accelerating Operational Excellence and Client Success
SOUTHBOROUGH, MA – October 30, 2024—Veristat, a scientific-minded global clinical...
Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team
To support sponsors around the globe bringing novel treatments to patients
SOUTHBOROUGH, MA – May 29, 2024 – Veristat, the Science-First...